Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordic Stem Cell is a Danish biotechnology company specializing in advanced stem cell therapies for orthopedic and regenerative medicine. The company focuses on providing autologous stem cell treatments, primarily utilizing mesenchymal stem cells (MSCs) derived from the patient's own adipose tissue or bone marrow to treat conditions such as osteoarthritis and joint degeneration. Their clinical approach emphasizes minimally invasive procedures designed to reduce pain and improve mobility without the need for major surgery. Nordic Stem Cell operates specialized clinics where they offer these regenerative treatments directly to patients, positioning themselves as a leader in the Nordic region's private regenerative healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nordic Stem Cell.